01 1Dipharma Francis Srl
02 1Piramal Healthcare (Canada) Limited
01 1Ibuprofen Lysine
02 1Ibuprofen-L-Lysinate
01 1India
02 1Italy
NDC Package Code : 46438-0003
Start Marketing Date : 2008-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55679-112
Start Marketing Date : 2006-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ibuprofen Lysinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibuprofen Lysinate, including repackagers and relabelers. The FDA regulates Ibuprofen Lysinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibuprofen Lysinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ibuprofen Lysinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ibuprofen Lysinate supplier is an individual or a company that provides Ibuprofen Lysinate active pharmaceutical ingredient (API) or Ibuprofen Lysinate finished formulations upon request. The Ibuprofen Lysinate suppliers may include Ibuprofen Lysinate API manufacturers, exporters, distributors and traders.
click here to find a list of Ibuprofen Lysinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ibuprofen Lysinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ibuprofen Lysinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ibuprofen Lysinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ibuprofen Lysinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ibuprofen Lysinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ibuprofen Lysinate suppliers with NDC on PharmaCompass.
We have 2 companies offering Ibuprofen Lysinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
